About UPSA
UPSA is a Healthcare company based in Rueil-malmaison (France) founded in 1935, and was acquired by Taisho Pharmaceutical in December 2018. Diversified pharmaceutical products are developed and distributed by UPSA. Its website upsa.com draws about 38 thousand monthly visits. UPSA offers products and services including Medications, Medical Devices, and Dietary Supplements. Its focus areas include Diversified Pharmaceuticals. Its legal entity is UPSA SAS.
Company details
UPSA was established in 1935 within the pharmaceutical industry. A diversified portfolio of products is maintained, encompassing various therapeutic areas. Operations involve research, manufacturing, and global distribution of medications. Services are extended to healthcare providers and consumers through established channels. The companys online presence is hosted at upsa.com, supporting information dissemination and stakeholder engagement.
- Headquarters Rueil-malmaison, France
- Stage Acquired
- SectorsHealthcare
- Website upsa.com
- Acquired by Taisho Pharmaceutical (Dec 2018)
- Legal Name Upsa Sas
- Latest Funding Round$1.7M (USD), Grant
Dec 2023
- InvestorsBristol-Myers Squibb
& 2 more
- Acquired by
Products & Services of UPSA
UPSA offers a comprehensive portfolio of products and services, including Medications, Medical Devices, and Dietary Supplements.
Products for relieving pain, fever, and benign ailments
Tools for health monitoring and treatment support
Supplements to enhance daily vitality and well-being
Funding Insights of UPSA
- Total Rounds 1
- Last Round Grant — $1.7M
- First Round $1.7M
(Dec 2023)
- Investors Count 1
All 1 funding rounds of UPSA with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2023 | $1.7M | Grant | – | – |
3 investors in total: 3 institutional.
Investors in UPSA
UPSA has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Bristol-Myers Squibb, Taisho Holdings and Ministry of Economy, Finance and Industrial and Digital Sovereignty.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| economie.gouv.fr | ||||
Manufacturer of drugs for oncology, HIV/AIDS, cardiovascular disease, rheumatoid arthritis, and hepatitis | 1887 | bms.com | New York, United States | |
Over-the-counter and prescription pharmaceutical drugs are manufactured. | 1912 | taisho-holdings.co.jp | Toshima City, Japan |
Investor details for UPSA
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of UPSA
52 people are tracked at UPSA (22 in leadership, 30 in team).
| Name | Role | Group |
|---|---|---|
Caroline Georges | Chief Of Staff To The CEO | Leadership |
Stéphanie Maquet | General Manager UPSA Benelux | Leadership |
Fabio Todesco | Finance Director Southern And Eastern Europe | Leadership |
Laure Lechertier | Executive Director Market Access, Communication And Public Affairs, Corporate Social Responsibility | Leadership |
Loic Bernard | General Manager Africa | Leadership |
Jean-Christophe Colombier | IT Business Partner | IT For Commercial | Leadership |
Guillaume Guitton | Chief Of Staff & PMO For Group HR Department | Leadership |
Renan Michel | Chief Of Staff To The CEO | Leadership |
Alessia Mazzaferro | HR Business Partner South & Central Eastern Europe | Leadership |
Victor Pinquier | Head Of International Controlling | Leadership |
Ilja Pohland | General Counsel And Head Of Compliance & Ethics | Leadership |
Stephane Michelot | Group Chief Financial Officer | Leadership |
Alessandro Vita | General Manager, Northern & Eastern Europe At UPSA | Leadership |
Louis Forestier | Corporate Development Director (m&a And Bd) | Leadership |
Camille Percepied | Head Of Global E-commerce And Digital Marketing And Country Lead China | Leadership |
Yvan Bontout | Business Performance, Strategy & Digital Director | Leadership |
Manuel Moreira | CTO - IT Infrastructure, Operations, Support & Cyber Security Director | Leadership |
Isabelle van Rycke | President And Chief Executive Officer | Leadership |
Alessio D'Ascenzo | Human Resources Director International Business And Talent Management | Leadership |
Nicolas Chan | Chief Digital And Data Officer | Leadership |
32 more people are available in the full profile.
Complete people profiles for UPSA
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of UPSA
4 dated milestones of UPSA across 88 years, from founding to its latest funding, stage changes and deals.
- Founded UPSA is founded.
- Exit Acquired by Bristol-Myers Squibb.
- Exit Acquired by Taisho Pharmaceutical.
- Funding First funding round of $1.7M.
Web traffic of UPSA
The website of UPSA (upsa.com) receives about 38.1K visits a month.
- Monthly visits38.1K
▲ 8.1% vs previous month
Websites whose visitors overlap most with UPSA. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
upsapharma.com | upsapharma.com | 100% | #9,121,634 | – | |
upsa-nosproduits.com | upsa-nosproduits.com | 98% | #1,192,165 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Upsa
Complete news archive for UPSA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about UPSA
UPSA was founded in 1935 and raised its 1st funding round 88 years after it was founded.
UPSA is headquartered in Rueil-malmaison, France. It is registered at Rueil-malmaison, Hauts-de-seine, France.
UPSA was established in 1935 within the pharmaceutical industry. A diversified portfolio of products is maintained, encompassing various therapeutic areas. Operations involve research, manufacturing, and global distribution of medications. Services are extended to healthcare providers and consumers through established channels. The companys online presence is hosted at upsa.com, supporting information dissemination and stakeholder engagement.
UPSA offers Medications, Medical Devices, and Dietary Supplements.
UPSA has 3 investors. Key investors include Bristol-Myers Squibb, Taisho Holdings, and Ministry of Economy, Finance and Industrial and Digital Sovereignty.
UPSA operates through Upsa Sas.
Yes. UPSA was acquired by Taisho Pharmaceutical in December 2018.